XtalPi, a China-based technology company in integrating artificial intelligence (AI) and robotics for drug and materials...
Arrowhead Pharmaceuticals, Inc. has announced the signing of an asset purchase agreement between Sanofi and Visirna Ther...
The Department of Rehabilitation Sciences at The Hong Kong Polytechnic University (PolyU) recently hosted the inaugural ...
The Hong Kong University of Science and Technology (HKUST) and Union Hospital, Tongji Medical College, Huazhong Universi...
Dr. Falk Pharma GmbH, a Germany-headquartered research-based pharmaceutical company specialising in digestive and metabo...
What are your plans for capacity expansion in biologics and ADC manufacturing? We are already among the largest biologi...
Tigermed, a leading global provider of clinical research solutions across the full lifecycle of global biopharmaceutical...
GSK plc has entered into agreements with China-based Hengrui Pharma to develop up to 12 innovative medicines, adding sig...
A cross-disciplinary research team from The Chinese University of Hong Kong (CUHK)’s Faculty of Medicine and Facul...
WuXi Biologics, a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced that f...
China Medical System Holdings Limited (CMS) has collaberated with the Singapore Exchange (SGX), expanding Chinese medica...
China-based Fangzhou Inc., a leader in internet healthcare solutions, has signed a Memorandum of Understanding (MoU) wit...
China's Sino Biopharm has announced the completion of a binding Sale and Purchase Agreement to acquire LaNova Medicines....
Chengdu Kanghua Biological Products Co. has announced that Shanghai Healthcare M&A Fund intends to acquire the compa...
CPHI & PMEC China 2025 has emerged as a cornerstone of the global pharmaceutical industry, driving collaboration, in...
In the newly released "Paediatric drug optimisation for respiratory syncytial virus (PADO-RSV) meeting report" by Global...
CPHI & PMEC China 2025 redefined China's pharmaceutical landscape, offering unparalleled opportunities for industry ...
Novo Nordisk has signed a Memorandum of Understanding (MoU) with TEDA Administrative Commission, agreeing to invest appr...
